tyrosine kinase modulators (Kyowa/Cephalon)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug Nametyrosine kinase modulators (Kyowa/Cephalon)
Drug Alias NameRTK effectors, Kyowa (Cephalon)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNerve growth factor receptor Trk-A activators
TargetsNerve growth factor receptor Trk-A
Therapy Area/IndicationsNerve DegenerationCraniocerebral TraumaAmyotrophic Lateral Sclerosis +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesJapan
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesKyowa Hakko Kogyo Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCephalon IncTap Pharmaceuticals IncKyowa Hakko Kogyo Co Ltd
Active IndicationsN/A
Inactive IndicationsNerve DegenerationCraniocerebral TraumaAmyotrophic Lateral Sclerosis +[4] 

Other Information

ATC CodeN/A
Related LinksN/A